Experience of using lenvatinib in the treatment of hepatocellular cancer at the Republican Oncology Center of the Republic of North Ossetia-Alania in 2018–2022. Balance of efficiency and accessibility in regional practice | Bolieva | Medical alphabet

Medical alphabet
Medicinskij alfavit

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

eng | рус

Preview

Medical alphabet

Advanced search

Archives

Download this PDF file

For citations:

Bolieva M.B., Yepkhiev A.A., Voronkova L.M., Zangionov G.E. Experience of using lenvatinib in the treatment of hepatocellular cancer at the Republican Oncology Center of the Republic of North Ossetia-Alania in 2018–2022. Balance of efficiency and accessibility in regional practice. Medical alphabet. 2024;(17):49-52. (In Russ.) https://doi.org/10.33667/2078-5631-2024-17-49-52

Views PDF (Rus): 5

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Petrikov Sergey S.

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

M. B. Bolieva
Republican Oncology Dispensary, Republic of North Ossetia – Alania
Russian Federation

Bolieva Marina B.- oncologist, head of Outpatient Chemotherapy Dept

Vladikavkaz

A. A. Yepkhiev
North Ossetian State Medical Academy
Russian Federation

Yepkhiev Alexander A. - PhD Med, head of Dept of Pathological Anatomy with Forensic Medicine

Vladikavkaz

L. M. Voronkova
Republican Oncology Dispensary, Republic of North Ossetia – Alania
Russian Federation

Voronkova Liya M. - oncologist, head of Inpatient Chemotherapy Dept

Vladikavkaz

G. E. Zangionov
Republican Oncology Dispensary, Republic of North Ossetia – Alania
Russian Federation

Zangionov Georgy E. - oncologist at Outpatient Chemotherapy Dep

Vladikavkaz

Notifications